From Single Nucleotide Polymorphisms to Constant Immunosuppression: Mesenchymal Stem Cell Therapy for Autoimmune Diseases
The regenerative abilities and the immunosuppressive properties of mesenchymal stromal cells (MSCs) make them potentially the ideal cellular product of choice for treatment of autoimmune and other immune mediated disorders. Although the usefulness of MSCs for therapeutic applications is in early pha...
Main Authors: | Chinnadurai, Raghavan, Waller, Edmund K., Galipeau, Jacques, Nooka, Ajay K. |
---|---|
Format: | Online |
Language: | English |
Published: |
Hindawi Publishing Corporation
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852726/ |
Similar Items
-
Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing
by: François, Moïra, et al.
Published: (2012) -
Single Nucleotide Polymorphism Clustering in Systemic Autoimmune Diseases
by: Charlon, Thomas, et al.
Published: (2016) -
Properties of Immature Myeloid Progenitors with Nitric-Oxide-Dependent Immunosuppressive Activity Isolated from Bone Marrow of Tumor-Free Mice
by: Forghani, Parvin, et al.
Published: (2013) -
Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation
by: Ruiz, Jesus, et al.
Published: (2015) -
Outcomes of Allogeneic Stem Cell Transplant (allo-SCT) Recipients in the Era of Newer Antifungal Agents
by: Shah, Nishi, et al.
Published: (2014)